Predictive ability of maximal tumor diameter on MRI for high-risk endometrial cancer
- 7 October 2016
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 41 (12) , 2484-2495
Abstract
To investigate the predictive ability of tumor size for deep myometrial invasion (≥50%) and metastatic lymphadenopathy, on maximal tumor diameter (MRI) of endometrial cancer. Our study population consisted of 105 patients (mean age: 59.8 years) with histologically confirmed endometrial cancer. All patients underwent preoperative pelvic MRI. Tumor maximal diameter (size) was calculated on multiple sequences, and the largest value was recorded. Logistic regression analysis was performed to investigate the association of maximal tumor diameter (MRI) with the depth of myometrial invasion and the presence of pelvic nodal metastases (histology); optimal tumor size cut-off for the prediction of deep myometrial involvement and nodal metastases was calculated using ROC analysis. Surgicopathological specimen examination was the standard of reference. Tumor size on MRI, independently predicted deep myometrial invasion. Optimal maximal tumor diameter cut-off for the prediction of deep myometrial invasion was 2 cm (SE 90%, SP 50.9%). When tumor size was used as a categorical variable in the multiple logistic regression model, tumor size >2 cm had 10.04 times greater odds of deep myometrial invasion (95% CI 3.34–30.17, p < 0.001). Optimal tumor size cut-off for prediction of nodal metastases was 4 cm (SE 60%, SP 76.9%). Multiple logistic regression analysis with nodal metastases as a dependent variable showed that tumor size >4 cm had 4.79 times greater odds for malignant dissemination to the lymph nodes (95% CI 1.00–23.09, p = 0.047). Maximal tumor diameter on preoperative MRI may be yet another prognosticator for deep myometrial invasion and metastatic lymphadenopathy in patients with endometrial carcinoma.Keywords
This publication has 27 references indexed in Scilit:
- Tumor SizeInternational Journal of Gynecological Cancer, 2013
- Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancerGynecologic Oncology, 2012
- Lymphadenectomy during endometrial cancer staging: Practice patterns among gynecologic oncologistsGynecologic Oncology, 2010
- Revised FIGO staging for carcinoma of the endometriumInternational Journal of Gynecology & Obstetrics, 2009
- Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical stagingGynecologic Oncology, 2008
- The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histologyInternational Journal of Gynecological Cancer, 2008
- Difficulties in Assessing the Depth of Myometrial Invasion in Endometrial CarcinomaInternational Journal of Gynecological Pathology, 2007
- Classical prognostic factors in patients with non-advanced endometrial cancer treated with postoperative radiotherapyReports of Practical Oncology and Radiotherapy, 2006
- Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancerGynecologic Oncology, 2005
- Laparoscopy versus laparotomy in endometrial cancer: First analysis of survival of a randomized prospective studyJournal of Minimally Invasive Gynecology, 2005